Gaixiang Xu
About
In The Last Decade
Gaixiang Xu
24 papers receiving 188 citations
Peers
Comparison fields: 5 of 41
- Molecular Biology 59
- Rheumatology 57
- Pathology and Forensic Medicine 55
- Hematology 46
- Oncology 42
Countries citing papers authored by Gaixiang Xu
This map shows the geographic impact of Gaixiang Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gaixiang Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gaixiang Xu more than expected).
Fields of papers citing papers by Gaixiang Xu
This network shows the impact of papers produced by Gaixiang Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gaixiang Xu. The network helps show where Gaixiang Xu may publish in the future.
Co-authorship network of co-authors of Gaixiang Xu
This figure shows the co-authorship network connecting the top 25 collaborators of Gaixiang Xu. A scholar is included among the top collaborators of Gaixiang Xu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gaixiang Xu. Gaixiang Xu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 5 | |
| 3 | 0 | |
| 4 | 1 | |
| 5 | 1 | |
| 6 | 5 | |
| 7 | 1 | |
| 8 | 1 | |
| 9 | 6 | |
| 10 | 3 | |
| 11 | 7 | |
| 12 | 7 | |
| 13 | Sorafenib in combination with low-dose-homoharringtonine as a salvage therapy in primary refractory FLT3-ITD-positive AML: a case report and review of literature. | 9 |
| 14 | Long-term disease control in a refractory multiple myeloma patient treated with bortezomib mono-therapy: a case report and review of literature. | 2 |
| 15 | High-dose methotrexate plus temozolomide as a salvage treatment in metastatic central nervous system Lymphoma: two cases report and review of literature. | 3 |
| 16 | Coexistence of multiple myeloma and clear cell renal cell carcinoma: a case report and review of literature. | 3 |
| 17 | 71 | |
| 18 | 2 | |
| 19 | 10 | |
| 20 | 38 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.